Zobrazeno 1 - 10
of 30
pro vyhledávání: '"I. B. Belyaeva"'
Autor:
I. B. Belyaeva, V. I. Mazurov
Publikováno v:
Современная ревматология, Vol 16, Iss 4, Pp 98-104 (2022)
The article presents an analysis of the therapeutic effect of the drug diacerein (D), which has been used in osteoarthritis (OA) for more than 20 years and is included in the clinical guidelines of the Association of Rheumatologists of Russia (2021)
Externí odkaz:
https://doaj.org/article/ddd34270cc8346f3b45480a57842584b
Publikováno v:
Современная ревматология, Vol 15, Iss 6, Pp 117-123 (2021)
The review presents an analysis of the therapeutic effect in osteoarthritis (OA) of the original complex injectable drug Alflutop (bioactive concentrate of small marine fish), which is one of the most widely used symptomatic slow acting drugs (SYSADO
Externí odkaz:
https://doaj.org/article/80f69fcda3774d4d89b49df2eb4897f7
Publikováno v:
Медицинский совет, Vol 0, Iss 19, Pp 78-88 (2020)
The article presents the actuality of the problem of hyperuricemia (HU) and gout in modern medicine, caused by the high prevalence and socio-economic consequences associated with the development in patients with these pathologies of earlier and more
Externí odkaz:
https://doaj.org/article/652aeb7e215d4908928f270f7949695f
Publikováno v:
Медицинский совет, Vol 0, Iss 11, Pp 146-153 (2020)
The article presents the relevance of the problem of postmenopausal osteoporosis (OP) in modern medicine, due to the social and economic consequences of fractures. The pathogenetic mechanisms of its formation are highlighted, indicating that during p
Externí odkaz:
https://doaj.org/article/bb15a7d96bd042848203464de5c9cf43
Publikováno v:
Медицинский совет, Vol 0, Iss 8, Pp 102-112 (2020)
The article discusses the participation of interleukin-6 (IL6) in the formation of pathogenetic mechanisms of immuno-inflammatory diseases (IID). IL6 is one of the central cytokine in progressive IID. The biological activity of IL6 is determined by i
Externí odkaz:
https://doaj.org/article/ad47cb706b664c16a5ff4f88ea905e15
Autor:
V. I. Mazurov, I. B. Belyaeva
Publikováno v:
Современная ревматология, Vol 13, Iss 4, Pp 116-123 (2019)
Significant successes in the use of biological agents (BA) have been achieved in the treatment of rheumatoid arthritis (RA); nonetheless, about 36% of patients cannot respond to therapy or achieve the expected effect. A new area in the treatment of R
Externí odkaz:
https://doaj.org/article/f03912e8e84c41239dc9d66369fad124
Autor:
V. I. Mazurov, I. B. Belyaeva, E. A. Trofimov, R. R. Samigullina, I. V. Oktyabrskaya, M. S. Petrova, O. V. Inamova, R. A. Bashkinov
Publikováno v:
Современная ревматология, Vol 13, Iss 3, Pp 22-29 (2019)
There are few studies of the efficiency of therapy with disease-modifying antirheumatic drugs (DMARDs) and biological agents (BAs) in patients with early rheumatoid arthritis (eRA) as part of a treat-to-target strategy.Objective: to investigate the e
Externí odkaz:
https://doaj.org/article/c4faf8fb3785402aae8d9e94123194a9
Autor:
M. Yu. Pervakova, A. L. Chudinov, S. V. Lapin, I. B. Belyaeva, V. I. Mazurov, T. V. Blinova, E. A. Surkova, V. L. Emanuel, O. V. Inamova
Publikováno v:
Научно-практическая ревматология, Vol 55, Iss 2, Pp 164-168 (2017)
α1-Antitrypsin (α1-AT) deficiency is a common genetic disorder characterized by low serum α1-AT levels and a clinical manifestation of pulmonary emphysema and liver disease. In addition to its classical manifestations, α1-AT deficiency frequently
Externí odkaz:
https://doaj.org/article/89721449a6d24e1ab71aeb3ed5f352c4
Publikováno v:
Медицинская иммунология, Vol 9, Iss 1, Pp 77-84 (2014)
Externí odkaz:
https://doaj.org/article/dc19d8ec2c9648c691f52f2584e397f5
Autor:
M. Y. Pervakova, V. L. Emanuel, O. N. Titova, S. V. Lapin, V. I. Mazurov, I. B. Belyaeva, A. L. Chudinov, T. V. Blinova, E. A. Surkova
Publikováno v:
International Journal of Rheumatology, Vol 2016 (2016)
The deficiency of alpha-1 protease inhibitor, or alpha-1-antitrypsin (A1AT), predisposes to chronic lung diseases and extrapulmonary pathology. Besides classical manifestations, such as pulmonary emphysema and liver disease, alpha-1-antitrypsin defic
Externí odkaz:
https://doaj.org/article/bc217c4043464d38b6a36aeb9c61d463